Supporting investment into the region and companies to find funding opportunities

Open funding calls

CLASP Fund Launch: Confronting Global Healthcare Challenges

September event will open the call for £2M worth of funds

STFC is to launch a major funding call this September, targeted towards pioneering healthcare research and development.

The council’s Challenge Led Applied Systems Programme (CLASP) provides funding to support the application and commercialisation of STFC research to address global challenges. These key research challenges include energy, environment, healthcare and security, and each year STFC puts out a call for funding applications to support projects in one of these areas.

On Friday 22nd September, STFC will hold a briefing event to launch the 2017 funding call, this year focused on addressing healthcare challenges. Up to £2 million is available to applicants with outstanding proposals that translate STFC research into industrial products for which there would be a demonstrable potential market.

The briefing event will allow delegates to discover more about CLASP, and to learn about the priority challenge areas identified by the healthcare community. Attendees will hear from agencies driving the healthcare agenda, and will meet with STFC scientists, and companies and users engaged in healthcare research. There will also be networking opportunities for potential applicants to meet and share ideas with potential project partners.

Find out more about the Challenge Led Applied Systems Programme.

Please register for this event, which will be held at the Royal College of Physicians, London, NW1 4LE on September 22nd 2017.

Investment accelerator pilot

This is a pilot programme for Innovate UK. It provides simultaneous grant funding and venture capital investment for early stage projects led by UK companies.

Up to £3 million of grant funding and £1.25 million of private equity investment is available for projects related to health and life sciences. This includes health, agriculture and biosciences.

We expect projects to have total costs of up to £150,000. The programme will provide 100% of project costs. Projects should last between 3 and 12 months.

The competition is open to single small and medium-sized enterprises (SMEs) who are looking for early stage grant funding and who wish to establish an equity relationship with a UK venture capital firm.

Competition opens Monday 8 May 2017
Briefing event in London
Monday 15 May 2017
Registration deadline Midday on Wednesday 28 June 2017
Application deadline Midday on Wednesday 5 July 2017

Further information can be found here

Biomedical Catalyst 2017 round 2 late stage award

The aim of this competition is to develop innovative healthcare technologies and processes that will help provide one or more of the following:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

This competition is for late stage awards only. It is seeking projects that test a well-developed concept and show effectiveness in a relevant environment.

We expect projects to range in size from total project costs of £250,000 to £4 million. Projects should last from 12 to 36 months. Projects must start by 1 February 2018 and end by 1 February 2021.

An SME must lead the project. The project must be carried out in the UK.

Competition opens Thursday 30 March 2017
Briefing event webinar for applicants Tuesday 4 April 2017
Registration deadline Midday on Wednesday 31 May 2017
Application deadline Midday on Wednesday 7 June 2017

Further details can be found here

SBRI funding competition: technology to improve IBD care and management

NHS Scotland, in conjunction with Highlands and Islands Enterprise and Scottish Government, will fund up to £400,000 for innovative technology and digital platforms that improve inflammatory bowel disease (IBD) care.

This is a Small Business Research Initiative (SBRI) competition. The aim is to develop technology that will improve the ongoing management of IBD for people living with the disease.

The competition is looking for proposals that:

  • help patients manage their health from home
  • promote independence and help people to be more involved in decisions about their care
  • facilitate easier and quicker communication with clinicians

Organisations can carry out the project on their own or with others.

This competition has 3 phases. We have allocated up to £75,000 for phase 1, up to £135,000 for phase 2 and up to £150,000 for phase 3:

  • phase 1: technical feasibility. Projects should last up to 8 weeks. Projects can range in size up to a total cost of £15,000 each
  • phase 2: prototype development and testing. Projects should last up to 6 months. Projects can range in size up to a total cost of £45,000 each
  • phase 3: pre-commercial testing to support continued development of the solution. Projects should last up to 1 year. Projects can range in size up to a total cost of £75,000 each.
Competition opens Monday 20 March 2017
Briefing event in Inverness for applicants Tuesday 4 April 2017
Registration deadline Midday on Wednesday 10 May 2017
Application deadline Midday on Wednesday 17 May 2017

Further information can be found here

Contact: Ashley Aitken

Ashley Aitken
Project Manager, Diagnostics

Ashley has experience of sales and marketing in the life science sector. She is a graduate of the University of Warwick, and specialised in Molecular Genetics.
Email Ashley

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu